Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 Degraders.

Saved in:
Bibliographic Details
Title: Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 Degraders.
Authors: Liu C; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Wang W; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Balog AJ; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Traeger S; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Panda M; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Kalidindi N; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Salinger A; Research & Early Development, Bristol Myers Squibb Company, Cambridge, Massachusetts 02141, United States., Amako Y; Research & Early Development, Bristol Myers Squibb Company, Cambridge, Massachusetts 02141, United States., Dongre AR; Research & Early Development, Bristol Myers Squibb Company, Cambridge, Massachusetts 02141, United States., Locke G; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Yu F; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Newitt JA; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Kiefer SE; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Naglich J; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Cheng D; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Sale H; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Ellsworth BA; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Regueiro-Ren A; Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2026 Jul 31; Vol. 17 (8), pp. 1864-1872. Date of Electronic Publication: 2026 Jul 31 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1948-5875
DOI:10.1021/acsmedchemlett.6c00262